[{"data":1,"prerenderedAt":-1},["ShallowReactive",2],{"doc-seo-336717-105":3,"detail-sidebar-cat-0-en-105":81,"doc-detail-336717-en":131},{"code":4,"msg":5,"data":6},0,"ok",{"site_id":7,"language":8,"slug":9,"title":10,"keywords":11,"description":12,"schema_data":13,"social_meta":74,"head_meta":76,"extra_data":78,"updated_unix":80},105,"en","the-expression-of-c-myc-cyclin-d1-and-ki-67mib-1-in-benign-and-malignant-thyroid-tissues-is-there-any-diagnostic-value","The expression of c-MYC, Cyclin D1 and Ki-67/MIB-1 in benign and malignant thyroid tissues: is there any diagnostic value?","","Aim to assess immunohistochemical expression and diagnostic value of c-MYC, Cyclin D1, and Ki-67/MIB-1 in thyroid follicular adenomas, follicular carcinomas, and anaplastic carcinomas, compared with adjacent non-neoplastic thyroid tissue. A retrospective cohort of patients post–total thyroidectomy was analyzed using tissue microarrays and anti-c-MYC, anti-Cyclin D1, and anti-Ki-67/MIB-1 staining with positivity evaluation. Results showed distinct nuclear c-MYC and Cyclin D1 patterns in neoplasms versus adjacent tissue, while cytoplasmic c-MYC positivity appeared in non-neoplastic tissue. A correlation between MIB1 and nuclear c-MYC supported prognostic relevance. Conclusions highlight marker-specific localization effects for diagnostic discrimination.",{"@graph":14,"@context":73},[15,34,56],{"@type":16,"itemListElement":17},"BreadcrumbList",[18,23,27,31],{"item":19,"name":20,"@type":21,"position":22},"https://docshare.wps.com","Home","ListItem",1,{"item":24,"name":25,"@type":21,"position":26},"https://docshare.wps.com/document/","Document",2,{"item":28,"name":29,"@type":21,"position":30},"https://docshare.wps.com/document/research-report/","Research & Report",3,{"item":32,"name":10,"@type":21,"position":33},"https://docshare.wps.com/document/the-expression-of-c-myc-cyclin-d1-and-ki-67mib-1-in-benign-and-malignant-thyroid-tissues-is-there-any-diagnostic-value/336717/",4,{"url":32,"name":10,"@type":35,"image":36,"author":41,"headline":10,"publisher":44,"fileFormat":47,"inLanguage":8,"description":12,"dateModified":48,"datePublished":49,"encodingFormat":47,"isAccessibleForFree":50,"interactionStatistic":51},"DigitalDocument",{"url":37,"@type":38,"width":39,"height":40},"https://docshare.wps.com/thumbnails/the-expression-of-c-myc-cyclin-d1-and-ki-67mib-1-in-benign-and-malignant-thyroid-tissues-is-there-any-diagnostic-value/336717.png","ImageObject",300,407,{"name":42,"@type":43},"Levi","Person",{"url":19,"name":45,"@type":46},"DocShare","Organization","application/pdf","2026-10-28","2026-09-21",true,{"@type":52,"interactionType":53,"userInteractionCount":55},"InteractionCounter",{"@type":54},"ViewAction",11,{"@type":57,"mainEntity":58},"FAQPage",[59,65,69],{"name":60,"@type":61,"acceptedAnswer":62},"What was the study’s objective regarding thyroid tumors?","Question",{"text":63,"@type":64},"The study examined immunohistochemical expression patterns of c-MYC, Cyclin D1, and Ki-67/MIB-1 in follicular adenomas, follicular carcinomas, and anaplastic carcinomas, and evaluated their diagnostic usefulness.","Answer",{"name":66,"@type":61,"acceptedAnswer":67},"How were the tissue samples and immunohistochemistry performed?",{"text":68,"@type":64},"A retrospective review was conducted on patients after total thyroidectomy. Tissue microarrays were built from neoplastic tissue and adjacent non-neoplastic thyroid tissue, followed by immunohistochemical staining for anti-c-MYC, anti-Cyclin D1, and anti-Ki-67/MIB-1 with positivity assessment.",{"name":70,"@type":61,"acceptedAnswer":71},"What diagnostic differences were observed between neoplastic and non-neoplastic tissues?",{"text":72,"@type":64},"Nuclear c-MYC and Cyclin D1 expression were higher in neoplasms than in adjacent non-neoplastic tissue, while cytoplasmic positivity occurred only in adjacent non-neoplastic tissue. Nuclear c-MYC positivity suggested exclusion of benign nature of thyroid lesions.","https://schema.org",{"og:url":32,"og:type":75,"og:title":10,"og:site_name":45,"og:description":12},"article",{"robots":77,"canonical":32},"index,follow",{"doc_id":79,"site_id":7},336717,1790100652,{"code":4,"msg":82,"data":83},"success",[84,88,92,96,101,106,111,115,120,123,127],{"id":22,"doc_module":4,"doc_module_name":25,"category_name":85,"show_sort_weight":86,"slug":87},"Story & Novel",90,"story-novel",{"id":26,"doc_module":4,"doc_module_name":25,"category_name":89,"show_sort_weight":90,"slug":91},"Literature",80,"literature",{"id":33,"doc_module":4,"doc_module_name":25,"category_name":93,"show_sort_weight":94,"slug":95},"Exam",70,"exam",{"id":97,"doc_module":4,"doc_module_name":25,"category_name":98,"show_sort_weight":99,"slug":100},5,"Comic",60,"comic",{"id":102,"doc_module":4,"doc_module_name":25,"category_name":103,"show_sort_weight":104,"slug":105},6,"Technology",50,"technology",{"id":107,"doc_module":4,"doc_module_name":25,"category_name":108,"show_sort_weight":109,"slug":110},7,"Healthcare",40,"healthcare",{"id":112,"doc_module":4,"doc_module_name":25,"category_name":29,"show_sort_weight":113,"slug":114},8,30,"research-report",{"id":116,"doc_module":4,"doc_module_name":25,"category_name":117,"show_sort_weight":118,"slug":119},9,"Religion & Spirituality",20,"religion-spirituality",{"id":118,"doc_module":4,"doc_module_name":25,"category_name":121,"show_sort_weight":118,"slug":122},"World Cup","world-cup",{"id":124,"doc_module":4,"doc_module_name":25,"category_name":125,"show_sort_weight":124,"slug":126},10,"Lifestyle","lifestyle",{"id":128,"doc_module":4,"doc_module_name":25,"category_name":129,"show_sort_weight":97,"slug":130},19,"General","general",{"code":4,"msg":82,"data":132},{"doc_id":79,"user_id":133,"nickname":42,"user_avatar":134,"doc_module":4,"category_id":112,"category_name":29,"doc_title":10,"doc_description":12,"doc_content":135,"file_id":136,"file_url":137,"file_type":138,"file_size":139,"view_count":55,"is_deleted":4,"is_public":22,"is_downloadable":22,"audit_status":22,"page_count":97,"language":140,"language_code":8,"site_id":7,"html_lang":8,"table_of_contents":141,"faqs":142,"seo_title":143,"seo_description":12,"update_tm":144,"read_time":145,"preview_page_count":33,"preview_urls":146},7971461740909,"https://ap-avatar.wpscdn.com/davatar_155a257f0dc6eb9ab79c44ca47cae57d","ORIGINAL PAPER  \nR J M E  \nRomanian Journal of Morphology & Embryology  \n[http://www.rjme.ro/](http://www.rjme.ro/)  \nThe expression of c-MYC, Cyclin D1 and Ki-67/MIB-1 in benign and malignant thyroid tissues: is there any diagnostic value?  \nEVROPI FOROZIDOU1), ANTONIA SYRNIOTI2), STYLIANI LASKOU3), ALEXANDROS POUTOGLIDIS4), KONSTANTINOS SAPALIDIS3), TRIANTAFYLLIA KOLETSA2)  \n1) Department of Otorhinolaryngology, Head and Neck Surgery, George Papanikolaou General Hospital, Thessaloniki, Greece  \n2) Department of Pathology, School of Medicine, Faculty of Health Sciences, Aristotle University of Thessaloniki, Greece  \n3)3rd Surgical Department, School of Medicine, Faculty of Health Sciences, Aristotle University of Thessaloniki, Greece  \n4) Department of Anatomy and Surgical Anatomy, School of Medicine, Faculty of Health Sciences, Aristotle University of Thessaloniki, Greece  \nAbstract  \nAim: To investigate the immunohistochemical (IHC) expression and the diagnostic value of c-MYC, Cyclin D1, and Ki-67/MIB-1 in follicular adenomas (FAs), follicular carcinomas (FCs), and anaplastic carcinomas (ACs) of the thyroid gland, as well as in their corresponding adjacent, non-neoplastic thyroid tissue (NNTT) . Materials and Methods: We conducted a retrospective study of patients who were pathologically diagnosed with FA, FC, or AC after total thyroidectomy. Tissue microarrays with cores taken from neoplastic and adjacent NNTT were constructed. Immunohistochemistry for anti-c-MYC, anti-Cyclin D1, and anti-Ki-67/MIB-1 antibodies was performed, and the positivity was evaluated. Results: Twenty-eight specimens were included. Nuclear c-MYC positivity was observed in 4/11 FCs, and 3/4 ACs, whereas cytoplasmic c-MYCpositivity was found in 16/24 NNTTs. Globally, there were statistically significant differences between neoplasms and NNTTs, with higher nuclear c-MYC and Cyclin D1 expression observed in neoplasms (p=0.017 and p=0.001, respectively). In contrast, cytoplasmic positivity was seen solely in NNTTs (p=0 .001) . Cyclin D1 positivity was noted in 11/13 FAs, 7/11 FCs, 2/4 ATCs, and only in one NNTT. A statistically significant correlation was found between MIB1 and c-MYC nuclear positivity (p=0 .040) . Conclusions: Our findings exhibit a clear difference in the IHC expression of c-MYC and Cyclin D1 between different types of thyroid tumors, as well as between the neoplastic and NNTT. Nuclear c-MYC positivity excludes the benign nature of a thyroid lesion, in contrast to cytoplasmic positivity, which demonstrates normal or hyperplastic nature. Keywords: c-MYC, Cyclin D1, Ki-67/MIB-1, molecular markers, follicular adenomas, thyroid cancer.  \n􀀕 Introduction  \nThyroid cancer is the most common malignancy of the endocrine system [1]. Papillary carcinomas (PCs) and follicular carcinomas (FCs) are mostly associated with favorable prognosis. On the other hand, medullary carcinomas (MCs) and especially anaplastic carcinomas (ACs) are considered entities with much worse outcome [2] .  \nThe molecular genetic alterations leading to carcinogenesis are not well understood. The presence of specific oncogenes or mutations to tumor suppressor genes has been related to the progression of well-differentiated neoplasms to poorly differentiated tumors [3] .  \nc-MYC is a proto-oncogene encoding a nuclear phosphoprotein responsible for tumor growth [4] . Both cytoplasmic and nuclear overexpression of c-MYC have been linked to tumorigenesis. The role ofc-MYC in thyroid cancer has been investigated in limited studies with controversial results [5, 6] .  \nCyclin D1 acts as a regulator of cyclin-dependent kinase (CDK)4 and CDK6, having a crucial role in the cell cycle  \nprogression [7]. According to literature, Cyclin D1 promotes tumor progression in renal cancer, gastric cancer, and lung cancer [8–10] . There is also a report about the high levels of its expression in thyroid cancer [11] . Recently, increased expression of Cyclin D1 and c-MYC has been associated wit","cbCaimO8WttcbNQk","https://ap.wps.com/l/cbCaimO8WttcbNQk","pdf",1310652,"English","# Abstract\n# Introduction\n# Aim\n# Materials and Methods","[{\"question\":\"What was the study’s objective regarding thyroid tumors?\",\"answer\":\"The study examined immunohistochemical expression patterns of c-MYC, Cyclin D1, and Ki-67/MIB-1 in follicular adenomas, follicular carcinomas, and anaplastic carcinomas, and evaluated their diagnostic usefulness.\"},{\"question\":\"How were the tissue samples and immunohistochemistry performed?\",\"answer\":\"A retrospective review was conducted on patients after total thyroidectomy. Tissue microarrays were built from neoplastic tissue and adjacent non-neoplastic thyroid tissue, followed by immunohistochemical staining for anti-c-MYC, anti-Cyclin D1, and anti-Ki-67/MIB-1 with positivity assessment.\"},{\"question\":\"What diagnostic differences were observed between neoplastic and non-neoplastic tissues?\",\"answer\":\"Nuclear c-MYC and Cyclin D1 expression were higher in neoplasms than in adjacent non-neoplastic tissue, while cytoplasmic positivity occurred only in adjacent non-neoplastic tissue. Nuclear c-MYC positivity suggested exclusion of benign nature of thyroid lesions.\"}]","The expression of c-MYC, Cyclin D1 and Ki-67/MIB-1 in benign and malignant thyroid tissues: is there any diagnostic value? | PDF",1790016347,13,[147,151,155,159],{"page_no":22,"url":148,"width":149,"height":150},"https://res-academy.cache.wpscdn.com/upload/kdocshare/2026-11-16/14a368f2266d3e4672e99d2250da6f5a.webp",983,1390,{"page_no":26,"url":152,"width":153,"height":154},"https://res-academy.cache.wpscdn.com/upload/kdocshare/2026-11-16/b08c7faf9813e1295569af3ed453200e.webp",982,1388,{"page_no":30,"url":156,"width":157,"height":158},"https://res-academy.cache.wpscdn.com/upload/kdocshare/2026-11-16/8c74582f1b68ef2ca07fe42b45712e25.webp",981,1387,{"page_no":33,"url":160,"width":161,"height":162},"https://res-academy.cache.wpscdn.com/upload/kdocshare/2026-11-16/f2abb33889f09eb5d46ba90c53564bae.webp",980,1385]